Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Another major launch for Alcon's prostaglandin analogue for glaucoma

July 15, 2002

Inspire presents melatonin analogues with IOP-reducing properties

July 10, 2002

Mast cell stabilizers synthesized at Alcon active in model of allergic conjunctivitis

June 20, 2002

Phase III results announced for INS-365 Ophthalmic in dry eye

June 19, 2002

Periostat enters clinical study for meibomianitis

June 19, 2002

Miravant and Bausch & Lomb to review SnET2 data with license option

June 13, 2002

Positive phase III results announced for ophthalmic implant for diabetic macular edema

June 12, 2002

CPMP recommends approval of Visudyne in occult subfoveal CNV secondary to AMD

June 3, 2002

Japanese labs identify new antiglaucoma agents

May 15, 2002

U.S. researchers successfully design soft cannabinoid analogues with potential in glaucoma Rx

May 14, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...